Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mycobacterium tuberculosis | Thymidylate kinase Tmk (dTMP kinase) (thymidylic acid kinase) (TMPK) | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | diacylglycerol kinase, putative | 0.0432 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0432 | 0 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase, putative | 0.0432 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0432 | 0 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0432 | 0 | 0.5 |
Plasmodium falciparum | diacylglycerol kinase, putative | 0.0432 | 0 | 0.5 |
Brugia malayi | diacylglycerol kinase | 0.0432 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0432 | 0 | 0.5 |
Trichomonas vaginalis | bmru protein, putative | 0.0432 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, zeta, iota, putative | 0.0432 | 0 | 0.5 |
Brugia malayi | diacylglycerol kinase | 0.0432 | 0 | 0.5 |
Leishmania major | diacylglycerol kinase-like protein | 0.0432 | 0 | 0.5 |
Trypanosoma brucei | Diacylglycerol kinase catalytic domain containing protein, putative | 0.0432 | 0 | 0.5 |
Trypanosoma cruzi | Diacylglycerol kinase catalytic domain containing protein, putative | 0.0432 | 0 | 0.5 |
Schistosoma mansoni | sphingoid long chain base kinase | 1.109 | 1 | 1 |
Brugia malayi | Ceramide kinase | 0.0432 | 0 | 0.5 |
Trypanosoma cruzi | Sphingosine kinase | 0.0432 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0432 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, zeta, iota, putative | 0.0432 | 0 | 0.5 |
Toxoplasma gondii | diacylglycerol kinase catalytic domain-containing protein | 0.0432 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, putative | 0.0432 | 0 | 0.5 |
Echinococcus multilocularis | sphingosine kinase 1 | 1.109 | 1 | 1 |
Onchocerca volvulus | 0.0432 | 0 | 0.5 | |
Trypanosoma cruzi | Sphingosine kinase | 0.0432 | 0 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase-like protein, putative | 0.0432 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 1.109 | 1 | 1 |
Onchocerca volvulus | Ceramide kinase 1 homolog | 0.0432 | 0 | 0.5 |
Plasmodium falciparum | diacylglycerol kinase, putative | 0.0432 | 0 | 0.5 |
Plasmodium vivax | diacylglycerol kinase, putative | 0.0432 | 0 | 0.5 |
Schistosoma mansoni | sphingosine kinase A B | 1.109 | 1 | 1 |
Toxoplasma gondii | diacylglycerol kinase, putative | 0.0432 | 0 | 0.5 |
Trichomonas vaginalis | bmru protein, putative | 0.0432 | 0 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 1.109 | 1 | 1 |
Plasmodium vivax | diacylglycerol kinase, putative | 0.0432 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0432 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, epsilon, putative | 0.0432 | 0 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase, putative | 0.0432 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 1.109 | 1 | 1 |
Leishmania major | diacylglycerol kinase, putative | 0.0432 | 0 | 0.5 |
Brugia malayi | Diacylglycerol kinase protein 2 | 0.0432 | 0 | 0.5 |
Toxoplasma gondii | diacylglycerol kinase accessory domain (presumed) domain-containing protein | 0.0432 | 0 | 0.5 |
Leishmania major | sphingosine kinase A, B, putative | 0.0432 | 0 | 0.5 |
Brugia malayi | Eye-specific diacylglycerol kinase | 0.0432 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 1.109 | 1 | 1 |
Trypanosoma cruzi | diacylglycerol kinase-like protein, putative | 0.0432 | 0 | 0.5 |
Trichomonas vaginalis | sphingosine kinase, putative | 0.0432 | 0 | 0.5 |
Trypanosoma brucei | diacylglycerol kinase, putative | 0.0432 | 0 | 0.5 |
Trypanosoma brucei | Sphingosine kinase | 0.0432 | 0 | 0.5 |
Trichomonas vaginalis | sphingosine kinase, putative | 0.0432 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 5.8 uM | Inhibition of Mycobacterium tuberculosis Thymidine monophosphate kinase by spectrophotometry | ChEMBL. | 20951473 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.